Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Forever bullish on the science...
View:
Post by fox7mf on Apr 23, 2023 8:19am

Forever bullish on the science...

...but it seems to be increasingly unlikely that a BD will materialize on or before June 2nd-6th (ASCO), especially one to the tune of the oft mentioned $5b-$15b usd vicinity. It would appear that there just isn't enough time to organically get the market cap up to the more appropriate $2b pre-buyout. My opinion & I'm no expert. Any thoughts? Good luck all!!!
Comment by Quentin30 on Apr 23, 2023 8:46am
There is almost no doubt in my mind that ONCY will postpone final data readout... by now they should have differentiation in the survival curves between Pax and Pela+Pax. That is more confirmation of IND-213. However, to get the deal in place, they will need to show that Pela+Pax+CPI is better than Pela+Pax, and that data must still be ongoing. That data will NOT be available in June. So, ONCY is ...more  
Comment by Lesalpes29 on Apr 23, 2023 9:03am
Still believe we will see something very positive this year. Why ask more options by ower greedy BOD if something positive is not going to happen before 2024! Why Rigby and Parsons are in the house! To make money and fast. The actual strategy is only to put more money in the pocket of every BOD members and cut ower gain by a little %. They work to create value for all shareholders but their ...more  
Comment by cardu on Apr 23, 2023 9:32am
I would agree that $2B would be a fair price to acheive.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities